Our group has reported that chronic arthritis decreases Pparα expression in liver and gastrocnemius, whereas the PPARα agonist fenofibrate improves arthritis-induced body weight loss and gastrocnemius muscle wasting by decreasing atrogenes and myostatin (11). This evidence concerns the gene MSTN and arthritic joint disease.